ClinicalTrials.gov
public full text
Public Domain
Botulinum Toxin Injections for Thoracic Outlet Syndrome
Botulinum toxin type A injected into the anterior and middle scalene muscles will reduce the irritation on the neurovascular structures at the interscalene triangle in subjects with TOS. This will lead to reductions in pain and paresthesias, and improvements in function when compared with injection of placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke#852011
- Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity#902330
- Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa#895089
- A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections#840725
- PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia#1094912
Record · ID 897569
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive